JH295 is a potent, irreversible, and selective inhibitor of NIMA-related kinase 2 (Nek2) with an IC50 of 770 nM; it inhibits cellular Nek2 through alkylation of Cys22 and shows no activity against mitotic kinases Cdk1, Aurora B, or Plk1, nor does it interfere with bipolar spindle assembly or the spindle assembly checkpoint.